Literature DB >> 28214887

Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?

Wei Zhang, Wenjie Xia, Zhengye Lv, Chao Ni, Yin Xin, Liu Yang.   

Abstract

Precision medicine and personalized medicine are based on the development of biomarkers, and liquid biopsy has been reported to be able to detect biomarkers that carry information on tumor development and progression. Compared with traditional 'solid biopsy', which cannot always be performed to determine tumor dynamics, liquid biopsy has notable advantages in that it is a noninvasive modality that can provide diagnostic and prognostic information prior to treatment, during treatment and during progression. In this review, we describe the source, characteristics, technology for detection and current situation of circulating tumor cells, circulating free DNA and exosomes used for diagnosis, recurrence monitoring, prognosis assessment and medication planning.
© 2017 The Author(s)Published by S. Karger AG, Basel.

Entities:  

Keywords:  Circulating free DNA; Circulating tumor cells; Exosomes; Liquid biopsy

Mesh：

Substances：

Year:  2017        PMID： 28214887     DOI： 10.1159/000458736

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN： 1015-8987


  64 in total

Review 1.  Liver metastases.

Authors:  Diamantis I Tsilimigras; Pnina Brodt; Pierre-Alain Clavien; Ruth J Muschel; Michael I D'Angelica; Itaru Endo; Rowan W Parks; Majella Doyle; Eduardo de Santibañes; Timothy M Pawlik
Journal:  Nat Rev Dis Primers       Date:  2021-04-15       Impact factor: 52.329

Review 2.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

3.  Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma.

Authors:  Jesse L Berry; Liya Xu; Irsan Kooi; A Linn Murphree; Rishvanth K Prabakar; Mark Reid; Kevin Stachelek; Bao Han A Le; Lisa Welter; Bibiana J Reiser; Patricia Chévez-Barrios; Rima Jubran; Thomas C Lee; Jonathan W Kim; Peter Kuhn; David Cobrinik; James Hicks
Journal:  Mol Cancer Res       Date:  2018-07-30       Impact factor: 5.852

Review 4.  Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy.

Authors:  Ahmed Elsherbini; Erhard Bieberich
Journal:  Adv Cancer Res       Date:  2018-06-09       Impact factor: 6.242

Review 5.  The functional roles of exosomes-derived long non-coding RNA in human cancer.

Authors:  Feiyu Chen; Ning Wang; Hor-Yue Tan; Wei Guo; Cheng Zhang; Yibin Feng
Journal:  Cancer Biol Ther       Date:  2019-02-11       Impact factor: 4.742

Review 6.  Recent Advances in the Label-Free Characterization of Exosomes for Cancer Liquid Biopsy: From Scattering and Spectroscopy to Nanoindentation and Nanodevices.

Authors:  Riccardo Di Santo; Sabrina Romanò; Alberto Mazzini; Svetlana Jovanović; Giuseppina Nocca; Gaetano Campi; Massimiliano Papi; Marco De Spirito; Flavio Di Giacinto; Gabriele Ciasca
Journal:  Nanomaterials (Basel)       Date:  2021-06-02       Impact factor: 5.076

Review 7.  Molecular Profiling of Liquid Biopsy Samples for Precision Medicine.

Authors:  Camila D M Campos; Joshua M Jackson; Małgorzata A Witek; Steven A Soper
Journal:  Cancer J       Date:  2018 Mar/Apr       Impact factor: 3.360

8.  Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer.

Authors:  Zhi-Jun Zhang; Xing-Guo Song; Li Xie; Kang-Yu Wang; You-Yong Tang; Miao- Yu; Xiao-Dong Feng; Xian-Rang Song
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-02

Review 9.  Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.

Authors:  Amogha Tadimety; Andrew Closson; Cathy Li; Song Yi; Ting Shen; John X J Zhang
Journal:  Crit Rev Clin Lab Sci       Date:  2018-02-01       Impact factor: 6.250

10.  The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study.

Authors:  L Yang; Z Lv; W Xia; W Zhang; Y Xin; H Yuan; Y Chen; X Hu; Y Lv; Q Xu; X Weng; C Ni
Journal:  Clin Transl Oncol       Date:  2017-12-14       Impact factor: 3.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.